Network origin in Robert B. Naso first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 24 | |
R.W. Johnson Pharmaceutical Research Institute
2
| Subsidiary | 2 | |
Univax Biologics, Inc.
 Univax Biologics, Inc. BiotechnologyHealth Technology Univax Biologics, Inc. developed and manufactured anti-infective products. The firm developed different products that prevented and treated infectious diseases and related complications through activation targeting of human immune system. Its products included vaccines for long-term protection, specific polyclonal antibodies for short-term protection and therapeutic intervention. The company was founded in 1988 and was located in Rockville, MD.
1
| Extinct | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert B. Naso via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer General Counsel | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| California Institute for Regenerative Medicine | General Government | Director/Board Member Director/Board Member | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Founder | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| JPMORGAN CHASE & CO. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of San Francisco | College/University | Masters Business Admin | |
| San Francisco State University | College/University | Undergraduate Degree | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Investor Relations Contact | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Investor Relations Contact | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact | |
| CERUS CORPORATION | Medical Specialties | Public Communications Contact | |
Advances In Kidney Disease & Health
 Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| Anderson School of Management | College/University | Masters Business Admin | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Berkeley | College/University | Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Medical Distributors | Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| FIBROGEN, INC. | Pharmaceuticals: Major | General Counsel | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Founder | |
| University of Michigan | College/University | Graduate Degree | |
| PACIFIC GAS AND ELECTRIC COMPANY | Gas Distributors | Corporate Officer/Principal | |
| TREE ISLAND STEEL LTD. | Metal Fabrication | Investor Relations Contact | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| BEYONDSPRING INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director of Finance/CFO |
Statistics
International
| United States | 47 |
| Canada | 3 |
| Netherlands | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Distribution Services | 3 |
| Government | 2 |
Operational
| Director/Board Member | 124 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 47 |
| Chairman | 31 |
| Director of Finance/CFO | 28 |
Most connected contacts
| Insiders | |
|---|---|
| John P. Walker | 39 |
| Elizabeth Czerepak | 31 |
| Ted Love | 31 |
| Dan Spiegelman | 24 |
| R. Greer | 23 |
| Keith Leonard | 20 |
| Paul Cleveland | 18 |
| Sylvia R. Wheeler | 14 |
| Hironori Hozoji | 13 |
| Steven Love | 13 |
| Anne-Marie S. Duliege | 11 |
| Christine van Heek | 9 |
| Julie Iwashita | 9 |
| Jeffrey H. Knapp | 8 |
| Peter R. Young | 8 |
- Stock Market
- Insiders
- Robert B. Naso
- Company connections
